What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review] Review uri icon
  • Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for CGM coverage required by the Centers for Medicare & Medicaid Services (CMS) ignore conclusive evidence that supports CGM use in various diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the CMS eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.

  • Link to Article
    publication date
  • 2021
  • published in
  • Diabetes
  • Drugs and Drug Therapy
  • Insurance, Reimbursement
  • Medicaid
  • Medicare
  • Monitoring, Physiologic
  • Additional Document Info
  • 23
  • issue
  • 9